Cargando…

UroVysion fluorescence in situ hybridization in urothelial carcinoma: a narrative review and future perspectives

The number of patients with urothelial carcinoma (UC) is high, with a corresponding demand for detecting UC easily and non-invasively. Cystoscopy and urine cytology, with widely known diagnostic accuracies, are the gold standards for identifying UC originating from the bladder. However, cystoscopy o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nagai, Takashi, Naiki, Taku, Etani, Toshiki, Iida, Keitaro, Noda, Yusuke, Shimizu, Nobuhiko, Isobe, Teruki, Nozaki, Satoshi, Okamura, Takehiko, Ando, Ryosuke, Kawai, Noriyasu, Yasui, Takahiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Review Article on Urinary Biomarkers of Urological Malignancies
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100858/ https://www.ncbi.nlm.nih.gov/pubmed/33968678 http://dx.doi.org/10.21037/tau-20-1207

Ejemplares similares

Evaluation of UroVysion for Urachal Carcinoma Detection
por: Hu, Zhiquan, et al.
Publicado: (2020)

UroVysion fluorescence in situ hybridization (UroVysion FISH) assay for detection of bladder cancer in voided urine of Turkish patients: a preliminary study
por: Dodurga, Yavuz, et al.
Publicado: (2013)

Refined pancreatobiliary UroVysion criteria and an approach for further optimization
por: Mettman, Daniel, et al.
Publicado: (2021)

Examination of Diagnostic Accuracy of UroVysion Fluorescence In Situ Hybridization for Bladder Cancer in a Single Community of Japanese Hospital Patients
por: Nagai, Takashi, et al.
Publicado: (2019)

A prospective comparison of UroVysion FISH and urine cytology in bladder cancer detection
por: Lavery, Hugh J., et al.
Publicado: (2017)

Performance of the UroVysion (®) FISH assay for the diagnosis of malignant effusions using two cutoff strategies
por: Rosolen, Débora C. B., et al.
Publicado: (2018)

Can Reflex UroVysion fluorescence in situ hybridization predict tumor recurrence during follow-up?
por: Kurien, Annamma, et al.
Publicado: (2007)

UroVysion(TM) Fluorescence In Situ Hybridization in Urological Cancers: A Narrative Review and Future Perspectives
por: Ke, Chunjin, et al.
Publicado: (2022)

AB051. Comparison of urine cytology and UroVysion FISH for upper tract urothelial carcinoma detection in Chinese patients
por: Peng, Weibin, et al.
Publicado: (2016)

Comparative study of ProEx C immunocytochemistry and UroVysion fluorescent in-situ hybridization assays on urine cytology specimens
por: Chang, Sue, et al.
Publicado: (2015)

Urinary biomarkers of urological malignancies
por: Fujita, Kazutoshi
Publicado: (2021)

UroVysion(™) fluorescence in situ hybridization (FISH) possibly has a high positive rate in carcinoma of non-urothelial lineages
por: Ke, Chunjin, et al.
Publicado: (2023)

Clinical Evaluation of Two Non-Invasive Genetic Tests for Detection and Monitoring of Urothelial Carcinoma: Validation of UroVysion and Xpert Bladder Cancer Detection Test
por: Kavcic, Niko, et al.
Publicado: (2022)

Extracellular vesicles in prostate cancer: a narrative review
por: Hatano, Koji, et al.
Publicado: (2021)

Urinary extracellular vesicles: a rising star in bladder cancer management
por: Urabe, Fumihiko, et al.
Publicado: (2021)

Toward urinary cell-free DNA-based treatment of urothelial carcinoma: a narrative review
por: Hayashi, Yujiro, et al.
Publicado: (2021)

A narrative review of urinary phospholipids: from biochemical aspect towards clinical application
por: Li, Xin, et al.
Publicado: (2021)

MiR-30b-3p and miR-126-3p of urinary extracellular vesicles could be new biomarkers for prostate cancer
por: Matsuzaki, Kyosuke, et al.
Publicado: (2021)

Narrative review of urinary glycan biomarkers in prostate cancer
por: Hatakeyama, Shingo, et al.
Publicado: (2021)

Risk for intravesical recurrence of bladder cancer stratified by the results on two consecutive UroVysion fluorescence in situ hybridization tests: a prospective follow-up study in Japan
por: Ikeda, Atsushi, et al.
Publicado: (2020)

A holistic comparative analysis of diagnostic tests for urothelial carcinoma: a study of Cxbladder Detect, UroVysion® FISH, NMP22® and cytology based on imputation of multiple datasets
por: Breen, Vivienne, et al.
Publicado: (2015)

Bacillus Calmette-Guerin therapy after the second transurethral resection significantly decreases recurrence in patients with new onset high-grade T1 bladder cancer
por: Iida, Keitaro, et al.
Publicado: (2016)

Complete surgical removal of multiple tumor lesions in malignant pheochromocytomas produces a good prognosis
por: Nozaki, Satoshi, et al.
Publicado: (2019)

Laparoscopic radical surgery produces a good prognosis in an elderly patient with small Wilms’ tumor
por: Ota, Yuya, et al.
Publicado: (2019)

NCL1, A Highly Selective Lysine-Specific Demethylase 1 Inhibitor, Suppresses Castration-Resistant Prostate Cancer Growth via Regulation of Apoptosis and Autophagy
por: Etani, Toshiki, et al.
Publicado: (2019)

Long-term survival of a patient with pulmonary metastatic urothelial carcinoma following metastasectomy
por: Hasebe, Kenichi, et al.
Publicado: (2018)

GPX2 promotes development of bladder cancer with squamous cell differentiation through the control of apoptosis
por: Naiki, Taku, et al.
Publicado: (2018)

Combination therapy with radiation and hyperthermia‐induced clinical complete response of small cell carcinoma of prostate
por: Kawai, Noriyasu, et al.
Publicado: (2022)

Metastasectomy as optimal treatment for late relapsing solitary brain metastasis from testicular germ cell tumor: a case report
por: Iida, Keitaro, et al.
Publicado: (2014)

Rare case of immunoglobulin G4‐related disease arising in gonadal glands with long‐term remission without steroid treatment: Discussion and literature review
por: Isobe, Teruki, et al.
Publicado: (2021)

Luteolin suppresses bladder cancer growth via regulation of mechanistic target of rapamycin pathway
por: Iida, Keitaro, et al.
Publicado: (2020)

A Case of Renal Primitive Neuroectodermal Tumor Confirmed by Fluorescence in situ Hybridization
por: Etani, Toshiki, et al.
Publicado: (2015)

Metastatic Urothelial Carcinoma with Glandular Differentiation That Confirmed the Response by Autopsy Specimen to Second-Line mFOLFOX6 (Fluorouracil, Oxaliplatin, and Leucovorin) plus Bevacizumab Chemotherapy
por: Naiki, Taku, et al.
Publicado: (2017)

Novel Closing Method Using Subcutaneous Continuous Drain for Preventing Surgical Site Infections in Radical Cystectomy
por: Hirose, Yasuhiko, et al.
Publicado: (2014)

Skeletal Muscle Mass Reduction Velocity as a Simple Prognostic Indicator for Patients with Metastatic Urothelial Carcinoma Receiving Second-Line Chemotherapy
por: Nagai, Takashi, et al.
Publicado: (2019)

Pelvic Hematoma After UroLift: A Case Report and Literature Review
por: Rodríguez-Fernández, Laura F, et al.
Publicado: (2023)

A Case of Metastatic Urothelial Carcinoma Treated with Pemetrexed as Third-Line Chemotherapy with Discussion and Literature Review
por: Iida, Keitaro, et al.
Publicado: (2015)

Inflammatory Myofibroblastic Tumor of the Urinary Bladder: A Case Report
por: Etani, Toshiki, et al.
Publicado: (2016)

Nonpalpable testicular pure seminoma with elevated serum alpha-fetoprotein presenting with retroperitoneal metastasis: a case report
por: Iwatsuki, Shoichiro, et al.
Publicado: (2016)

Pure Lymphoepithelioma-Like Carcinoma Originating from the Urinary Bladder
por: Nagai, Takashi, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_e5btuiogocmilbg5m8mq21l2m9